Kidney Cancer Clinical Trial

Clinical Trial Finder Kidney Cancer Trials

Perfusion CT Monitoring to Predict Treatment Efficacy in Renal Cell Carcinoma

See Locations Near You

Summary

This pilot clinical trial studies perfusion computed tomography (CT) in predicting response to treatment in patients with advanced kidney cancer. Comparing results of diagnostic procedures done before, during, and after targeted therapy may help doctors predict a patient's response to treatment and help plan the best treatment.

View Eligibility Criteria

Eligibility Criteria

Inclusion Criteria:

Suspected or biopsy-proven renal cell carcinoma
Treatment planned with sunitinib, pazopanib, sorafenib, bevacizumab, axitinib, nivolumab alone or in combination with an investigational agent
Ability to understand and willingness to sign a written informed consent document

Exclusion Criteria:

Serum creatinine greater than or equal to 1.7 mg/dL
Severe allergy to contrast agent
Any contraindication for undergoing a CT scan
Pregnancy or unwillingness to use preventative measures if a woman of child-bearing potential

Study is for people with:

Kidney Cancer

Estimated Enrollment:

19

Study ID:

NCT01926990

Recruitment Status:

Completed

Sponsor:

Stanford University

Check Your Eligibility

Let’s see if you might be eligible for this study.

What is your age and gender ?

Submit

There is 1 Location for this study

See Locations Near You

Stanford University Cancer Institute
Stanford California, 94305, United States

How clear is this clinincal trial information?

Study is for people with:

Kidney Cancer

Estimated Enrollment:

19

Study ID:

NCT01926990

Recruitment Status:

Completed

Sponsor:


Stanford University

How clear is this clinincal trial information?

×

Introducing, the Journey Bar

Use this bar to access information about the steps in your cancer journey.

Please confirm you are a US based health care provider:

Yes, I am a health care Provider No, I am not a health care provider